Xtant Medical to Participate in the Canaccord Genuity 2026 Musculoskeletal Conference

Xtant Medical to Participate in the Canaccord Genuity 2026 Musculoskeletal Conference [Accessibility Statement] Skip NavigationBELGRADE, Mont., Feb. 25, 2026 /PRNewswire/ -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal, orthopedic, and wound care disorders, today announced that Sean Browne, CEO, Scott Neils, CFO, and Mark Schallenberger, COO, will be participating in the Canaccord Genuity 2026 Musculoskeleta ...